Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)
Hong Kong · Delayed Price · Currency is HKD 0.3700
-0.0100 (-2.63%)
Jan 30, 2026, 2:59 PM HKT
HKG:8217 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 27.51 | 36.2 | 35.14 | 104.6 | 92.75 | 168.3 | Upgrade | |
Revenue Growth (YoY) | -32.25% | 3.02% | -66.41% | 12.77% | -44.89% | -52.58% | Upgrade |
Cost of Revenue | 28.73 | 35.22 | 33.26 | 107.48 | 91.71 | 170.58 | Upgrade |
Gross Profit | -1.21 | 0.98 | 1.88 | -2.88 | 1.04 | -2.28 | Upgrade |
Selling, General & Admin | 8.05 | 9.35 | 7.57 | 5.8 | 10.63 | 8.67 | Upgrade |
Other Operating Expenses | -0.79 | -0.87 | -0.01 | -0.03 | -0.01 | -1.39 | Upgrade |
Operating Expenses | 10.9 | 12.23 | 6.12 | 9.79 | 22.55 | 13.7 | Upgrade |
Operating Income | -12.11 | -11.25 | -4.24 | -12.67 | -21.5 | -15.98 | Upgrade |
Interest Expense | -0.72 | -0.72 | -0.72 | -0.72 | -0.73 | -0.27 | Upgrade |
Interest & Investment Income | - | - | - | - | - | 0.02 | Upgrade |
Other Non Operating Income (Expenses) | 0.2 | 0.2 | -0.36 | 0.02 | 0.34 | -0.69 | Upgrade |
EBT Excluding Unusual Items | -12.63 | -11.77 | -5.32 | -13.37 | -21.9 | -16.92 | Upgrade |
Gain (Loss) on Sale of Investments | 32.35 | 5.35 | -13.29 | -1.39 | 1.99 | 9.38 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.56 | 0.09 | -11.97 | Upgrade |
Asset Writedown | - | - | - | - | -0.51 | -2.62 | Upgrade |
Other Unusual Items | - | - | - | 0.51 | - | 6.62 | Upgrade |
Pretax Income | 20.24 | -5.9 | -17.43 | -9.96 | -20.21 | -15.51 | Upgrade |
Income Tax Expense | - | - | - | - | -0.06 | -2.38 | Upgrade |
Net Income | 20.24 | -5.9 | -17.43 | -9.96 | -20.15 | -13.13 | Upgrade |
Net Income to Common | 20.24 | -5.9 | -17.43 | -9.96 | -20.15 | -13.13 | Upgrade |
Shares Outstanding (Basic) | 302 | 302 | 302 | 302 | 201 | 87 | Upgrade |
Shares Outstanding (Diluted) | 306 | 302 | 302 | 302 | 201 | 87 | Upgrade |
Shares Change (YoY) | 1.52% | - | - | 50.37% | 131.26% | 11.29% | Upgrade |
EPS (Basic) | 0.07 | -0.02 | -0.06 | -0.03 | -0.10 | -0.15 | Upgrade |
EPS (Diluted) | 0.07 | -0.02 | -0.06 | -0.03 | -0.10 | -0.15 | Upgrade |
Free Cash Flow | -4.93 | -7.27 | 3.72 | 32.23 | -19.52 | 28.54 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.02 | 0.01 | 0.11 | -0.10 | 0.33 | Upgrade |
Gross Margin | -4.41% | 2.71% | 5.35% | -2.75% | 1.12% | -1.36% | Upgrade |
Operating Margin | -44.01% | -31.08% | -12.06% | -12.11% | -23.18% | -9.50% | Upgrade |
Profit Margin | 73.56% | -16.30% | -49.61% | -9.53% | -21.72% | -7.80% | Upgrade |
Free Cash Flow Margin | -17.91% | -20.08% | 10.59% | 30.81% | -21.04% | 16.96% | Upgrade |
EBITDA | -12.03 | -11.17 | -4.16 | -12.59 | -21.36 | -13.93 | Upgrade |
EBITDA Margin | -43.73% | -30.86% | -11.83% | -12.04% | -23.03% | -8.28% | Upgrade |
D&A For EBITDA | 0.08 | 0.08 | 0.08 | 0.08 | 0.14 | 2.05 | Upgrade |
EBIT | -12.11 | -11.25 | -4.24 | -12.67 | -21.5 | -15.98 | Upgrade |
EBIT Margin | -44.01% | -31.08% | -12.06% | -12.11% | -23.18% | -9.50% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.